in caricamento ...

STJ – St. Jude Medical

Scritto il 22 Marzo 2006 alle 11:10 da Danilo DT

St. Jude Medical, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices. The company operates in five segments: Cardiac Rhythm Management (CRM), Neuromodulation (Neuro), Cardiac Surgery (CS), Cardiology (CD), and Atrial Fibrillation (AF). Its CRM segment products include bradycardia pacemaker systems and tachycardia implantable cardioverter defibrillator systems. The company’s CS segment offers mechanical and tissue heart valves, and valve repair products. Its Neuro segment provides neurostimulation devices. The company’s CD segment offers vascular closure devices, guidewires, hemostatis introducers, and other interventional cardiology products. St. Jude Medical’s EF segment products comprise electrophysiology catheters, cardiac mapping systems, and ablation systems. The company markets and sells its products through direct sales force and independent distributors in the United States, Europe, and Japan, as well as in Canada, Latin America, Australia, New Zealand, and the Asia-Pacific region. St. Jude Medical was founded in 1976 and is headquartered in St. Paul, Minnesota.

KEY STATISTICS:
http://finance.yahoo.com/q/ks?s=STJ

STJ -> TECNICAMENTE, VISTI I BUONI FONDAMENTALI E LE OTTIME PROSPETTIVE, E’ DA CONSIDERARE SERIAMENTE AL RAGGIUNGIMENTO DI QUOTA 43 $, IN CONCOMITANZA DEL SUPPORTO STATICO/DINAMICO.